PFG
ICPT

PAX Financial Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

PAX Financial Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,019
Closed -$193K – 218
2021
Q3 		$193K Buy
+13,019
New +$208K 0.05% 181

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PAX Financial Group's ICPT Position: Q4 2021 in Review

PAX Financial Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 13,019 shares — an estimated $193K sold.

PAX Financial Group first reported a position in ICPT in Q3 2021 and held it in 1 quarter. The position peaked at $193K in Q3 2021. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

  • PAX Financial Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • PAX Financial Group sold 13,019 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $193K.
  • PAX Financial Group first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
  • PAX Financial Group's Intercept Pharmaceuticals, Inc. position peaked at $193K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on PAX Financial Group's 13F filing for Q4 2021, filed 7 Feb 2022.